Related Experiment Video
Updated: Sep 3, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Autoimmune thyroiditis and celiac disease do not worsen endothelial function in subjects with type 1 diabetes: an
Martina Parise1, Antonio Cutruzzolà2, Faustina Barbara Scavelli3
1Department of Health Science, University Magna Græcia, Viale Europa, Località Germaneto, Catanzaro, Italy.
Insights
Type 1 diabetes (T1D) patients with autoimmune thyroiditis (AT) or coeliac disease (CD) showed no increased arterial wall thickening or endothelial dysfunction. This suggests that coexisting AT and CD do not worsen cardiovascular risk in T1D patients.
Area of Science:
- Endocrinology and Immunology
- Cardiovascular Research
- Diabetology
Background:
- Type 1 diabetes (T1D) is often linked with autoimmune thyroiditis (AT) and coeliac disease (CD).
- The impact of these coexisting autoimmune conditions on cardiovascular risk in T1D patients remains unclear.
- This study investigates the effects of AT and CD on vascular health in T1D.
Purpose of the Study:
- To evaluate the effects of coexisting autoimmune thyroiditis (AT) and coeliac disease (CD) on arterial wall thickening.
- To assess the impact of AT and CD on endothelial function in patients with Type 1 diabetes (T1D).
Main Methods:
- Observational study analyzing data from 110 Type 1 diabetes (T1D) patients.
- Vascular assessment included Echo-Doppler evaluation of common carotid artery intima-media thickness (CCA IMT) and flow-mediated dilation (FMD).
- Statistical analyses compared T1D patients with and without concomitant autoimmune diseases (AT/CD).
Main Results:
- No significant difference in CCA IMT was observed between T1D patients with and without AT/CD.
- Flow-mediated dilation (FMD) results were comparable across T1D groups, indicating similar endothelial function.
- The presence of AT and/or CD did not lead to increased arterial wall thickening or impaired endothelial function.
Conclusions:
- Type 1 diabetes patients with coexisting autoimmune thyroiditis or coeliac disease do not exhibit worse vascular damage.
- Arterial wall morphology (CCA IMT) and endothelial function (FMD) are similar in T1D patients with or without AT/CD.
- Concomitant AT and CD do not appear to exacerbate cardiovascular risk markers in T1D patients.
Background:
Type 1 diabetes (T1D) is frequently associated with autoimmune thyroiditis (AT) and coeliac disease (CD). Whether the coexistence of multiple autoimmune diseases increases cardiovascular risk is uncertain. We evaluated the effects of AT and CD on arterial wall thickening and endothelial function in patients with T1D.
Methods:
This observational study analyzed data from T1D patients regularly followed by the Diabetes Care Centre. Clinical and biochemical characteristics and micro and macrovascular complications were collected from the electronic medical records. All subjects performed Echo-Doppler to evaluate Intima-Media Thickness (IMT) of the common carotid artery (CCA) and endothelial function by the flow-mediated dilation (FMD) technique. The statistical analyses were performed by SPSS for Macintosh. Comparison between means was performed using the t-test for unpaired data and the Mann-Whitney U test. The ANalysis Of VAriance and the Tukey posthoc test were applied to compare patients with and without other autoimmune diseases, and control subjects. The p-value for statistical significance was set at p < 0.05.
Results:
A total of 110 patients were enrolled. Among these, 69 had T1D and 41 T1D and AT and or CD, of whom 33 AT, 7 CD, and 1 both AT and CD. The mean age was 35 years, mean HbA1c was 7.6%, and mean diabetes duration 18 years. The IMT of the CCA was not significantly different between T1D patients with and without concomitant autoimmune diseases (with AT and CD: right CCA 603 ± 186 µ, left 635 ± 175 µ; without AT and CD: right CCA 611 ± 176 µ, left CCA 631 ± 200 µ). FMD was also comparable between T1D groups, with AT and CD 7.9 ± 4.2%; without AT and CD 8.8 ± 4.4%.
Conclusion:
Patients with T1D and concomitant AT and or CD show no worse morphological or functional vascular damage, evaluated by CCA IMT and brachial artery flow-mediated dilation, than patients with T1D alone.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Psychoneuroimmunology: Diabetes and Cancer
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...

